Andere Sprachen Repligen Corporation

Aktien

870980

US7599161095

RGEN

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 25.04.2024			% 5 Tage	% 1. Jan.
165,7 ^USD	-1,31 %		+5,48 %	-7,86 %

08.04.	REPLIGEN CORPORATION : RBC Capital Markets behält seine Kaufempfehlung bei	ZM
20.03.	Transcript : Repligen Corporation Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 03:00 PM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Repligen to Report First Quarter 2024 Financial Results	17.04.
Repligen : Investor Presentation April 2024 Presentations	02.04.
Repligen Appoints Maggie A. Pax to Board of Directors	19.03.
Repligen Corporation Appoints Maggie A. Pax as Board of Directors	19.03.
Repligen Insider Sold Shares Worth $681,348, According to a Recent SEC Filing	13.03.
Repligen Insider Sold Shares Worth $3,298,632, According to a Recent SEC Filing	12.03.
Repligen Insider Sold Shares Worth $866,204, According to a Recent SEC Filing	27.02.
Sector Update: Health Care Stocks Flat to Lower Premarket Wednesday	21.02.
Sector Update: Health Care	21.02.
Repligen Q4 Adjusted Earnings, Revenue Decline; Issues 2024 Guidance; Shares Fall Premarket	21.02.
Sartorius fällt - Ausblick von Repligen enttäuscht	21.02.
Repligen: Q4 Earnings Snapshot	21.02.
(RGEN) REPLIGEN CORPORATION Expects Fiscal Year 2024 EPS Range $1.42 - $1.49	21.02.
Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 Revenue $155.7M, vs. Street Est of $156.3M	21.02.
Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 EPS $0.33, vs. Street Est of $0.34	21.02.
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results	21.02.
Repligen Corporation Provides Earnings Guidance for the Year 2024	21.02.
Repligen Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	21.02.
Repligen Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21.02.
Stocks Decline Pre-Bell as Fed Outlook, Rates Weigh; Asia Mixed, Europe Mostly Up	21.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Repligen Corporation

Aktien

870980

US7599161095

RGEN

Andere Sprachen

Filter